Next Article in Journal
Adverse Events Associated with Nirmatrelvir/Ritonavir: A Pharmacovigilance Analysis Based on FAERS
Previous Article in Journal
Formulation of Lipid-Based Nanoparticles for Simultaneous Delivery of Lapatinib and Anti-Survivin siRNA for HER2+ Breast Cancer Treatment
Previous Article in Special Issue
In Vitro Characterization of Inhibitors for Lung A549 and Leukemia K562 Cell Lines from Fungal Transformation of Arecoline Supported by In Silico Docking to M3-mAChR and ADME Prediction
 
 
Article

Article Versions Notes

Pharmaceuticals 2022, 15(12), 1454; https://doi.org/10.3390/ph15121454
Action Date Notes Link
article xml file uploaded 23 November 2022 13:16 CET Original file -
article xml uploaded. 23 November 2022 13:16 CET Update https://www.mdpi.com/1424-8247/15/12/1454/xml
article pdf uploaded. 23 November 2022 13:16 CET Version of Record https://www.mdpi.com/1424-8247/15/12/1454/pdf
article supplementary file uploaded. 23 November 2022 13:16 CET - https://www.mdpi.com/1424-8247/15/12/1454#supplementary
article html file updated 23 November 2022 13:17 CET Original file -
article html file updated 1 March 2023 00:30 CET Update -
article html file updated 3 March 2023 22:17 CET Update https://www.mdpi.com/1424-8247/15/12/1454/html
Back to TopTop